Eric Cannon, PharmD, FAMCP, discusses how precision medicine advancements and biomarker development can enable targeted ...

The lungs of patients with cystic fibrosis harbor a different microbial makeup, including less diversity of species, than the lungs of healthy individuals, according to a study published Wednesday ...

Between the first week of pulmonary rehabilitation and the last recorded session before transplantation, lung transplant ...

In a recent study published in the Journal of Cystic Fibrosis, Don Ingber and his group at the Wyss ... In 2010, his team created the first lung-on-a-chip, a small in vitro model that recreates the ...

Cystic fibrosis is a life-threatening genetic disease that clogs the lungs with thick, sticky mucus, leading to chronic infections and severe organ damage. Despite breakthrough medications that have ...

The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...

Researchers at The University of Manchester in collaboration with Manchester University NHS Foundation Trust (MFT) are launching a new Cystic Fibrosis Innovation Hub to accelerate the development of ...

While many of the patients that come through the UCSF Fresno Cystic Fibrosis Center are still young, they have transitioned ...

Severe cases may require a lung transplant. There is no cure for cystic fibrosis (CF), but advances in treatment have extended both the life expectancy and quality of life of people living with ...

All states should adopt updated screening protocols so more newborns with cystic fibrosis can be diagnosed in the first weeks of life, when interventions can have the greatest benefit, according to ...

Owlstone Medical ("Owlstone"), the global leader in Breath Biopsy ® for applications in early disease detection and precision medicine, today announced that the Cystic Fibrosis Foundation has ...